<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
    xmlns:admin="http://webns.net/mvcb/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:content="http://purl.org/rss/1.0/modules/content/">
    <channel>
            <title>Journal of Child, Adult Vaccines and Immunology</title>
            <link>https://www.vaccinesimmunojournal.com/feed</link>
            <description>Introduction
Vaccines are perhaps medical science&apos;s most widely used and effective products. At the turn of the last century it was discovered that particular microbes gave rise to specific diseases and this link led to the development of vaccines. Immunology is the study of the structure and function of the immune system. It assists the science of vaccine development and how the immune system responds to vaccines.
Journal of Child, Adult Vaccines and Immunology is an initiative of Heighten Science to publish manuscripts that can become basis for improving the effectiveness of existing vaccines, as well as the development of novel vaccines and vaccine delivery systems. Journal of Child, Adult Vaccines and Immunology publishes ongoing scientific advances in vaccine development accompanied by scientific advances in epidemiological methods which can continue to inform the development and monitoring of new vaccines.
Reasons for Publishing
Vaccines are recommended based on age, prior vaccinations, health, lifestyle and occupation. However, the society still lacks the awareness and information to determine exactly which vaccines an individual need at what age and which vaccines are coming up. The development of new and effective vaccine products cannot proceed without a detailed understanding of the immune correlates of protection.
Therefore the manuscripts published in The Journal of Child, Adult Vaccines and Immunology provides essential information for rational vaccine design, and also guides the parameters to be measured when evaluating vaccine efficacy.</description>

                    <item>
            <type>Review Article</type>
            <title>Examining the Effects of High Poverty and Unemployment on Rural Urban Migration in Nigeria and its Consequences on Urban Resources and Rural Decline</title>
            <author>Tochukwu S Ezeudu*, Bilyaminu Tukur</author>
            <pubDate>2024-04-02 10:54:39</pubDate>
            <description>This study examines the intricate interplay among poverty, unemployment, education, and rural-urban migration in Nigeria, employing both quantitative and qualitative analyses. Quantitative data were analyzed using SPSS software, computing descriptive and inferential statistics such as regression analysis. Quantitative findings reveal income inequality, with many individuals earning below average. Education emerges as a key determinant of economic opportunities, with higher education associated with better outcomes. Moreover, poverty and unemployment exhibit a strong positive correlation with adverse outcomes, emphasizing the need for targeted interventions. Qualitative insights delve into the motivations behind rural-urban migration, shedding light on the economic drivers compelling individuals to seek opportunities in urban areas. Participants&amp;rsquo; narratives uncover the challenges faced by migrants, from housing to accessing essential services. Additionally, the role of remittances in sustaining sending communities is highlighted, underscoring their significance. This study underscores the multidimensionality of poverty, unemployment, and migration and emphasizes the need for holistic, evidence-based approaches to promote inclusive development. Recommendations include investments in education, job creation, social safety nets, income inequality reduction, and support for migrant integration. These measures can contribute to equitable economic growth and improved well-being in Nigeria.</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1012.pdf</link>
        </item> 
                    <item>
            <type>Case Report</type>
            <title>Case Report of a Child with Beta Thalassemia Major in a Tribal Region of India</title>
            <author>Neha Chauhan, Prakash Narayan, Mahesh Narayan, Manisha Shukla*</author>
            <pubDate>2023-09-08 16:33:29</pubDate>
            <description>Introduction: Thalassemia is an inherited blood disorder of haemoglobin (Hb) synthesis, which affects different regions around the world. India has the largest number of children with beta-thalassemia major in the world, particularly in the tribal population. Heterozygous conditions are milder and even go unreported than the condition of homozygous where regular blood transfusion is required.Case report: This report focuses on a case of major beta-thalassemia in a child, whose parents are beta thalassemia minor to intermediate conditions, and who was treated by blood transfusion once a month. However, Thalassemia may be cured by allogeneic hematopoietic stem cell transplantation, although not everyone is a good candidate. Genetic counselling, prenatal diagnosis, and selective termination of affected fetuses are effective ways to control thalassemia.Discussion and conclusion: The paper reports a unique case of Thalassemia in rural India. The blood disorder while commonly presented in a juvenile whose parents were Thalassemia positive resulted in the termination of a fetus diagnosed with it. It archives the story of the parents who are now in the process of planning future offspring while mitigating disease risk. The case leads the way for effective management and containment of hereditary genetic disorders through carrier detection while planning alliances and offspring.</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1011.pdf</link>
        </item> 
                    <item>
            <type>Case Study</type>
            <title>Male in Early Adolescence Presenting with Guillain&#45;Barré Syndrome Following BECOV2D Vaccine</title>
            <author>Vinit Suri*, Kanika Suri, Kunal Suri, Priyal</author>
            <pubDate>2023-08-07 12:16:04</pubDate>
            <description>COVID vaccination has been associated with serious disorders including thrombosis with thrombocytopenia syndrome (TTS), Guillain-Barr&amp;eacute; syndrome (GBS), and myocarditis. GBS has been reported in adults following COVID-19 infection and rarely following the COVID-19 vaccination. Post COVID vaccination GBS has been associated with prominent and early facial diplegia and quadriplegia. Extension of the COVID vaccination program to the pediatric age group of 5 to 17 years has exposed this population to the adverse effects of the vaccination. Only a few case reports of post-vaccination GBS have been reported in the pediatric age group without any data on the true prevalence. We report a case of a male in his early adolescence with GBS presenting as facial diplegia and rapid quadriplegia following the BECOV2D, (Corbevax) vaccination. Our case is the first case of GBS reported following BECOV2D, (Corbevax) vaccination and highlights the presentation with prominent and early diplegia, which is similar to the presentation in adults.</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1010.pdf</link>
        </item> 
                    <item>
            <type>Research Article</type>
            <title>Follow&#45;up of patients with sarcoidosis in an internal medicine unit from a hospital in Asturias, Spain. Analysis of extrapulmonary manifestations</title>
            <author>Gómez de la Torre R,Charca Benavente L,Yllera Gutiérrez C,Rolle V,Colunga Argüelles D</author>
            <pubDate>2022-09-02 12:11:26</pubDate>
            <description>Sarcoidosis is a multisystem disease of unknown origin that is characterized by non-caseating epithelioid granuloma formation within various organs, mainly the lungs [1].&amp;nbsp;The objective of this study is the analysis of sarcoidosis patients affected by pulmonary manifestation alone or extrapulmonary expression.</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1009.pdf</link>
        </item> 
                    <item>
            <type>Brief Communication</type>
            <title>Impact of coronavirus pandemic on safety and time of administration of subcutaneous immunotherapy among pediatric patients</title>
            <author>Ana Margarida Mesquita,Ricardo Moço Coutinho,José Luís Plácido,Alice Coimbra</author>
            <pubDate>2022-09-02 11:48:58</pubDate>
            <description>Introduction: Allergen immunotherapy is the only targeted therapy that can modify the natural course of allergic diseases. In pediatric patients, SCIT with aeroallergens is an effective treatment and should be considered as a preventive strategy in the treatment of allergic diseases, even though one of the major concerns about it is its safety. The main purposes of this study were to assess the safety of SCIT ultra-rush schedules with polymerized extracts in a pediatric population and to determine the impact of the COVID-19 pandemic on the safety and time of administration of subcutaneous immunotherapy among pediatric patients.Methods: A retrospective medical records review of patients under 18 years of age undergoing SCIT was made and re-scheduling due to restrictions imposed by the COVID-19 pandemic was recorded.&amp;nbsp;Results: A total of 192 pediatric patients were included. Fifty-nine (31%) had local reactions and systemic reactions were not reported. In March 2020, the first case of COVID-19 was diagnosed in Portugal and all non-urgent appointments and procedures were postponed. In our group of pediatric patients, 43 (22%) were referred to primary care, 38 (20%) stopped AIT definitively and 111 (58%) maintained administrations in the hospital. Only 2 (2%) of them had reactions upon reinitiation.&amp;nbsp;Conclusion: In this study, the ultra-rush protocol using polymerized extracts was safe in pediatric patients. Although the effectiveness of AIT may be compromised due to prolonged suspension of the treatment, it is important to note that despite longer interruptions, administrations may continue without compromising safety, maintaining shorter visits and a lower number of injections.</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1008.pdf</link>
        </item> 
                    <item>
            <type>Short Communication</type>
            <title>RBD targeted COVID vaccine and full length spike&#45;protein vaccine (mutation and glycosylation role) relationship with procoagulant effect</title>
            <author>Luisetto M,Tarro G,Farhan Ahmad Khan,Khaled Edbey,Mashori GR,Yesvi AR,Latyschev OY</author>
            <pubDate>2021-04-26 00:00:00</pubDate>
            <description>Related COVID vaccine production many different strategies was followed by the producers.
Observing some rare event of thrombosis after some COVID-19 vaccination, it is interesting to verify if the Target used for the manufacturing can be involved in a different procoagulant activity or not.
Some vaccine are suspended in some country or under a deep new verify- investigation by the regulatory agency. (EU or USA).
This fact it is relevant.
The target SPIKE-PROTEIN FULL LENGTH modified or not or towards the RBD domain can be a relevant factor.</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1007.pdf</link>
        </item> 
                    <item>
            <type>Review Article</type>
            <title>Zn2+ Ions&#45;Immune Virucidal activities for children and adults with preventions against 2019&#45;nCoV and COVID&#45;19 infection</title>
            <author>Tsuneo Ishida</author>
            <pubDate>2020-07-28 00:00:00</pubDate>
            <description>Zinc induced pediatric preventing respiratory 2019-nCoV is required that supplementation with zinc gluconate 20 mg in Zn deficient children resulted in a nearly twofold reduction of acute lower respiratory infections as well as the time to recovery. Zinc supplementation in children is associated with a reduction in the incidence and prevalence of pneumonia. Preventing 2019-nCoV pneumonia is required that zinc supplementation alone (10 to 20 mg) for more than 3 months significantly reduces in the rate of pneumonia. zinc pediatric intake may be required to be effective range 10～20 mg/d for 2019-CoV prevention, 10～30 mg/d for reduction of COVID-19 bronchitis, and 20～30 mg/d for recovery from COVID-19 pneumonia, in which Zn2+ could bind with viral surface proteins by Zn2+ions-centered tetrahedrally coordination pattern.
On the other hand, for aults, the zinc-homeostatic immune concentration may provide a protective role against the COVID-19 pandemic, likely by improving the host&amp;rsquo;s resistance against viral infection. 50 mg of zinc per day might provide an additional shield against the COVID-19 pandemic, possibly by increasing the host resistance to viral infection to minimize the burden of the disease. In order to prevent that an outbreak of respiratory sickness caused by a novel coronavirus (COVID-19) has become a serious public threat and disrupted many lives,assessing the efficacy of FDA-approved Zn-ejector drugs such as disulfiram combined with interferon to treat COVID-19 infected patients has been proposed. The key strategies for preventing lung damages include avoiding direct lung infection, altering host-virus interactions, promoting immune responses, diluting virus concentrations in lung tissues by promoting viral migration to the rest of the body, maintaining waste removal balance, protecting heart function and renal function, avoiding other infections, reducing allergic reactions and anti-inflammatory. The interactions had been found on the binding specificity by Zn2+ ions-centered tetrahedral geometric coordination of the inhibitors against 3C and 3C-like proteases. In addition, transient zinc chelation TPEN and EPDTC have been noted as preventing virus replication.
Zinc-induced ROS production in COVID-19 respiratory ailment and pneumonia occurs both in children and adults. In children.
ROS production in zinc (Ⅱ)-immune pediatric patient with COVID-19 bronchitis and pneumonia cannot be elucidated yet. In adults, zinc induced ROS generation in pulmonary COVID-19 infected cells is that alterations of ROS-producing and scavenging pathways that are caused by respiratory viral infections are implicated in inﬂammation, lung epithelial disruption, and tissue damage, and, in some cases, even pulmonary ﬁbrosis. The involvement of oxidative stress in cell deaths caused during RNA virus infection and ROS production is correlated with host cell death.</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1006.pdf</link>
        </item> 
                    <item>
            <type>Opinion</type>
            <title>To be and not to be: With wisdom and grace or stupidity and disgrace after the SARS&#45;CoV2 outbreak</title>
            <author>Yue Zhang</author>
            <pubDate>2020-04-03 00:00:00</pubDate>
            <description>The day before yesterday, it was shameful for some politicians, especially President Trump, to label SARS-CoV2 virus as discriminatory &amp;ldquo;Chinese Virus&amp;rdquo;. Politicians should be more professional and graceful, and distance themselves from the independence of the academy if something remains unknown to them. Besides, there were two months for President Trump to prepare the Americans for this Virus [1]; unfortunately, could he have given more attention to his duty of anti-SARS-CoV2 action, despite spending time to defending against the impeachment of his presidency? Besides, in line with this idea, presidential candidate Hillary Clinton wrote: &amp;rdquo;The president is turning to racist rhetoric to distract from his failures to take the coronavirus seriously early on, make tests widely available and adequately prepare the country for a period of crisis. Don&amp;rsquo;t fall for it. Don&amp;rsquo;t let your friends and family fall for it&amp;rdquo;.</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1005.pdf</link>
        </item> 
                    <item>
            <type>Research Article</type>
            <title>Educational strategy to increase knowledge and risk perception about sexually transmitted infection in polytechnic students</title>
            <author>Alba Cortes Alfaro,Damarys Chacón O’farrill</author>
            <pubDate>2020-03-19 00:00:00</pubDate>
            <description>Introduction: The incidence of STI-HIV/AIDS is on the rise, making adolescents a vulnerable group at risk.
Objective: To increase the knowledge and perception of risk about STI-HIV/AIDS, through Educational Intervention in students of the Polytechnic Institute &amp;uml;Hermanos G&amp;oacute;mez&amp;uml; of the Municipality San Jos&amp;eacute; de las Lajas, Mayabeque Province.
Method: Quasi-experimental study, intervention at the &amp;uml;Hermanos G&amp;oacute;mez Polytechnic Institute, of the Municipality of San Jos&amp;eacute; de la Lajas, through affective, participatory, animation and reflection techniques, the universe being made up of 17 students aged 16-17 years of specialty in Industrial Chemistry, during the period from December 2014 to November 2015. The variables used were: knowledge about STI-HIV/AIDS and perception of risk towards said diseases.
Results: after the intervention, an increase in the level of knowledge of the main STIs in the study was evident: Syphilis, Condylomas, HIV/AIDS, Gonorrhea, Trichomonas, Candida Albicans and Herpes simplex, which were adequately identified by 60%; 71% recognized the routes of sexual transmission, 60% the typical clinical manifestations, an increase in the levels of knowledge about the use of condoms to prevent STIs, and in the same way the perception of risk in an 83% after the intervention.
Conclusion: After the intervention, there was an increase in knowledge of STIs, transmission routes, clinical manifestations, condom use, and risk perception.</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1004.pdf</link>
        </item> 
                    <item>
            <type>Research Article</type>
            <title>Demographic survey and management outcome of Post&#45;Neonatal Tetanus at the Ekiti state university teaching hospital, Ado Ekiti </title>
            <author>Ajite AB,Ogundare EO,Oluwayemi IO,Olatunya OS,Babatola A,Taiwo A,Komolafe A,Fatunla O</author>
            <pubDate>2019-04-23 00:00:00</pubDate>
            <description>Background: Tetanus continues to threaten the survival of children in spite of it being a vaccine preventable disease. The objective of this study was to determine the prevalence of post-neonatal tetanus, review the vaccination of affected children, complications encountered and the outcome among affected children in a tertiary health institution in southwestern Nigeria.
Methods: The study was a retrospective study. Case notes of children outside neonatal life admitted to the Paediatric ward with clinical diagnosis of tetanus between January 2012 and October 2018 were retrieved and evaluated to identify socio-demographic and clinical characteristics. A review of the immunization history and cards was done where the immunization cards were available.
Results: 21children with post-neonatal tetanus were admitted over a period of six years (November 2012 to October 2018) with a prevalence of 0.3%. The M:F was 3.2:1. The mean age in years was 10.14 &amp;plusmn;3.44 while the age range of the subjects was 4 to 16years. None of the patients had booster doses of tetanus toxoid (TT) outside the infancy period. Nine (42.9%) subjects had no previous TT vaccination, 2 (9.5%) had 3 doses of TT vaccine in infancy but developed tetanus at age &amp;ge;9 years, 1(4.8%) subject had a dose of TT while the remaining 9subjects had no proof of previous TT vaccination. The percentage mortality was 19% (4 out of 21). All the patients that died had no prior record of TT vaccination. Complications identified included laryngeal spasm and autonomic dysfunction.
Conclusion: Post-neonatal tetanus is still common in our locality because booster doses of Tetanus Toxoid are not part of the national immunization schedule. Complete dose of tetanus toxoid vaccination during infancy and booster doses at school entry is necessary and should be part of school health programme to forestall post-neonatal tetanus</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1003.pdf</link>
        </item> 
                    <item>
            <type>Letter to Editor</type>
            <title>Importance of prevention&#45;A letter to the editor</title>
            <author>Akanksha Rathi</author>
            <pubDate>2018-01-19 00:00:00</pubDate>
            <description>In today&amp;rsquo;s busy world, people don&amp;rsquo;t even have the time to fall ill. Diseases don&amp;rsquo;t just demand time but also physical efforts, mental peace, loss of work, distress of loved ones and financial loss. According to a report published in Harvard business review, each year in India, 39 million people are pushed into poverty by out-of-pocket payments for healthcare, with households on average devoting 5.8% of their expenditures to medical care [1].</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1002.pdf</link>
        </item> 
                    <item>
            <type>Letter to Editor</type>
            <title>Exploring the Debate on Vaccines</title>
            <author>D. John Doyle</author>
            <pubDate>2017-09-11 00:00:00</pubDate>
            <description>A thought-provoking debate in the popular literature concerning vaccination has blossomed in recent years [1-6]. While &amp;ldquo;traditionalists&amp;rdquo; support universal immunization against a variety of infectious diseases, many influential individuals hold that vaccinations do far more harm than good. The web sites vactruth.com and anhinternational.org are typical web sites to visit to understand their concerns. &amp;nbsp;More details on the debate, offering commentary on both sides of the issue, can be explored at wikipedia.org/wiki/Vaccine_controversies. In essence, however, those arguing for the universal use of vaccines point to the many millions of lives saved since mass immunization programs were introduced and further argue that resistance to routine vaccination is almost always based on false information. Those arguing against the routine use of vaccines usually either contend that the vaccines are unsafe (often maintaining that vaccine components such as formaldehyde or thimerosal are highly toxic) or alternately argue that governments simply do not have the moral authority to encroach on an individual&amp;rsquo;s freedom to make medical decisions for themselves or for their children.</description>
            <link>https://www.vaccinesimmunojournal.com/articles/jcavi-aid1001.pdf</link>
        </item> 
                        <!-- end item Block -->
    </channel>
</rss>